Abstract
AbstractThe phosphoinositide (PI) cycle second messenger system mediates the effect of muscarinic receptor binding. Inositol, which is an essential substrate for phosphoinositide synthesis penetrates the blood‐brain barrier poorly, and is vulnerable to depletion. Lithium uncompetitively inhibits inositol‐1‐monophosphatase, a key enzyme in the recycling of inositol for the PI messanger system. There is evidence for cholinergic overactivity in depression from clinical and experimental observations. Among these, pyridostigmine (PYD) stimulated growth hormone (GH) release is found to be elevated relative to healthy controls. PYD/GH responses were examined in six healthy male volunteers before and after 10 days of lithium administration. GH responses did not differ significantly after lithium from those observed at baseline. These results suggest that lithium does not significantly inhibit cholinergically mediated GH secretion in healthy volunteers and provide further support for the selective action of lithium on upregulated cholinergic tracts, consistent with uncompetitive inhibition of the phosphoinositide cycle.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Human Psychopharmacology: Clinical and Experimental
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.